Skip to Content
Morningstar

Teva Pharmaceutical Industries Ltd TEVJF

Morningstar Rating
Unlock
Stock PINX Rating as of
$15.03 +3.28 (27.91%)
View Full Chart
As of Delayed Price Closed
Unlock our analysis with Morningstar Investor
Start Free Trial

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

View History
TEVJF is trading within a range we consider fairly valued.
Price
$11.71
Fair Value
$77.59
Uncertainty
High
1-Star Price
$52.45
5-Star Price
$2.17
Economic Moat
Jrss
Capital Allocation
Fwbgvflh
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if TEVJF is a good fit for your portfolio.
Get 7 Days Free

News

View All

Trading Information

Previous Close Price
$11.75
Day Range
$15.03–15.03
52-Week Range
$7.03–15.87
Bid/Ask
$14.81 / $18.37
Market Cap
$17.02 Bil
Volume/Avg
200 / 9,706

Key Statistics

Price/Earnings (Normalized)
4.45
Price/Sales
0.82
Dividend Yield (Trailing)
—
Dividend Yield (Forward)
—
Total Yield
—

Company Profile

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Large Value
Total Number of Employees
37,851
Website
https://www.tevapharm.com

Competitors

Valuation

View More
Metric
TEVJF
VTRS
RDY
Price/Earnings (Normalized)
 4.453.9018.37
Price/Book Value
 1.830.663.36
Price/Sales
 0.820.873.37
Price/Cash Flow
 8.264.0214.87
Price/Earnings
TEVJF
VTRS
RDY

Financial Strength

Metric
TEVJF
VTRS
RDY
Quick Ratio
 0.470.671.80
Current Ratio
 0.891.672.55
Interest Coverage
 0.181.3546.52
Quick Ratio
TEVJF
VTRS
RDY

Profitability

Metric
TEVJF
VTRS
RDY
Return on Assets (Normalized)
 6.70%7.07%15.57%
Return on Equity (Normalized)
 39.00%16.57%21.70%
Return on Invested Capital (Normalized)
 13.54%9.85%20.10%
Return on Assets
TEVJF
VTRS
RDY
See how this stock stacks up to its competitors with Morningstar Investor
Start Free Trial

Drug Manufacturers - Specialty & Generic Industry Comparables

Screen in Investor
Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ZTS
Zoetis Inc Class AMphctcghxLvgqn$79.4 Bil
MKKGY
Merck KGaA ADRThyzxvkkrChmttcr$79.0 Bil
HLN
Haleon PLC ADRJbfbmjscrWtvb$38.5 Bil
VTRS
Viatris IncHpbgbvgtSlmn$13.1 Bil
RDY
Dr Reddy's Laboratories Ltd ADRLpmwjwpyKzw$11.6 Bil
CTLT
Catalent IncBkxckzjcPwghx$10.0 Bil
CURLF
Curaleaf Holdings IncLfjwbdnjDgl$4.2 Bil
PRGO
Perrigo Co PLCCzhqznysvGrym$4.0 Bil
PBH
Prestige Consumer Healthcare IncFwlqwcmtCgmnf$3.2 Bil
GTBIF
Green Thumb Industries IncQmrzyclcltYqgb$3.1 Bil

Sponsor Center